Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy. 1976

R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011929 Razoxane An antimitotic agent with immunosuppressive properties. ICRF-159,ICRF-186,NSC-129943,Razoxane Mesylate, (R)-Isomer,Razoxane, (R)-Isomer,Razoxin,ICRF 159,ICRF 186,ICRF159,ICRF186,NSC 129943,NSC129943
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1977, Cancer treatment reports,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1975, Cancer chemotherapy reports,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1980, Cancer treatment reports,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1976, Journal of clinical pharmacology,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
March 1978, Cancer treatment reports,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1984, Anticancer research,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
August 2015, Investigational new drugs,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1985, Medical and pediatric oncology,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
January 1978, Cancer treatment reports,
R E Bellet, and P F Engstrom, and R B Catalano, and R H Creech, and M J Mastrangelo
May 1978, Cancer treatment reports,
Copied contents to your clipboard!